MMP9 and colorectal cancer: Enalapril, an antihypertensive medication, can re-sensitize colorectal cancer cells to 5-fluorouracil chemotherapy by inhibiting NF-kB and reducing MMP-9, a pro-angiogenic molecule released in NETosis (49).